William Lauder: BCRF and The Estée Lauder Companies Commit $15 Million to Breast Cancer Research
William Lauder/LinkedIn

William Lauder: BCRF and The Estée Lauder Companies Commit $15 Million to Breast Cancer Research

William Lauder, Chair, Board of Directors at The Estée Lauder Companies, shared on LinkedIn:

“My mother, Evelyn H. Lauder, believed deeply in the power of research to change and save lives. When she started this work more than 30 years ago, she had a very clear vision: to put breast cancer out of business.

I am proud to see The Estée Lauder Companies and The Breast Cancer Research Foundation continue to carry her vision forward.

Today, as breast cancer incidence rates continue to climb among younger women, we need to better understand why. This $15 million commitment to launch the Global Research Initiative on Breast Cancer in Younger Women will bring together leading researchers from around the world to pursue answers to some of the most important questions about this disease.

My mother understood that progress begins with research. It also means giving talented people the resources and support they need to do their best work.”

You can also read:

HER2CLIMB-05 Strengthens First-Line Maintenance in HER2-Positive Metastatic Breast Cancer With Tucatinib
William Lauder: BCRF and The Estée Lauder Companies Commit $15 Million to Breast Cancer Research